Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
—·5h
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
TickersGLPChannelsstocksCountriesusaCategoriespharma
Open original source ↗Published
7/21/2026, 11:35:46 AM
Fetched
7/21/2026, 12:08:05 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
en